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Objective: To know the spectrum of surgical site infections in general surgical patients so that specific strategies 
can be developed to decrease the morbidity caused by these infections. 
Material and Methods: All the patients who underwent general surgical operations on an emergency basis at the 
surgical unit of the District headquarters teaching hospital Rawalpindi from 01-01-2016 to 31-12-2017 were 
evaluated for surgical site infections. Surgical site infections suspected clinically were confirmed by culture and 
sensitivity. Involved flora and their sensitivity to various antibiotics were also determined. 
Results: Among 2202 emergency operated patients, two hundred and thirty-seven patients (10.76%) had surgical 
site infection confirmed on culture and sensitivity (C/S) report.  About sixty-five percent of patients were male. 
Of two hundred and thirty-seven positive patients, the twenty-nine patient underwent laparotomy for penetrating 
and blunt abdominal trauma. Staph aureus was present in one hundred and forty-five (79.67%) patients.  E.coli 
was the commonest Gram-ve micro-organism (70.95%). Forty-six patients (19.40%) were sensitive to 
Cefoperazone sodium followed by twenty patients (8.43%) to Piperacillin sodium and twenty-one (8.86%) each to 
Amikacin and Linezolid. 
Conclusion: Surgical site infection causes a significant rise in morbidity on the surgical floor. Most of the 
causative microorganisms are becoming resistant to routine antibiotics. Sensitivity to the broader spectrum of 
antibiotics like Cefoperazone and Linezolid is increasing. 








Surgical site infections (SSIs) are defined as infections 
occurring up to 30 days after surgery (or up to one 
year after surgery in patients receiving implants) and 
affecting either the incision or deep tissue at the 
operation site.1 SSI may present as redness, delayed 
healing, fever, pain, tenderness, warmth, swelling, or 
discharge of pus. 
Surgical site infections (SSI) are commonest 
nosocomial infections after urinary tract infections 
(UTI), responsible for increasing cost, substantial 
morbidity, and occasional mortality related to surgical 
operations and continue to be the major problem even 
in hospital with most modern facilities and standard 
protocols of pre-operative preparation and antibiotic 
prophylaxis.2,3,16 SSI rate varies from 2.5% to 41.9% 
and accounts for some 20% of healthcare-associated 
infections.2,4 Patients with severe shock at the time of 
presentation, anemia, poorly controlled diabetes and 
other systemic illnesses are at great risk of developing 
SSI.5 Presence of contamination also increases the risk 
of SSI.6,7 Causative pathogens are acquired 
endogenously from the patient’s flora or exogenously 
from contact with operative room personnel or the 
environment.8 Most SSIs are caused by Staphylococcus 
aureus, E.coli, and Enterococci.8,9 Antimicrobial 
resistance among these and other clinically important 
pathogens is an increasing problem.10 
Antimicrobial resistance poses a serious threat to 
human health and requires rational use of antibiotics 
to curb further spreading.11 Consistent with proper 
antimicrobial stewardship, antibiotic prophylaxis 
should use an appropriate drug and optimize the dose 
and duration of treatment to minimize toxicity and 
conditions for the selection of resistant bacterial 
strains.12,13 Methicillin-resistant Staphylococcus aureus 
is on the rise nowadays. This strain of Staph aureus is 
resistant to most of the commonly used antibiotics.14 
Many resistant strains of bacterial pathogens are 
sensitive to new broad-spectrum antibiotics like 
Cefoperazone, linezolid, and Tigecyclin.15 Surgical site 
infections (SSI) are a major cause of morbidity in 
surgical patients and they increase health care costs 
considerably due to prolonged stay in hospital and 
extra usage of the hospital facilities like costly 
antibiotics, use of ventilator support, etc.16 
We must adhere to guidelines for the prevention of 
SSIs in form of good patient preparation, aseptic 
practice, attention to surgical technique, and rational 
antimicrobial prophylaxis.17 
Materials and Methods 
 
Purpose of the study: This study was conducted at 
our teaching hospital to know the spectrum of SSI in 
general surgical patients so that we can develop 
specific strategies to decrease the morbidity and 
mortality caused by SSIs. 
This observational study was conducted in the surgical 
department of the DHQ Teaching hospital Rawalpindi 
from 01-01-2016 to 31-12-2017. All the patients 
admitted to surgical wards after emergency surgery 
were included in the study. Elective surgeries were 
excluded from the study as most of t such cases are 
clean surgeries. Informed consent was taken from all 
the patients or their attendants. Before the start of the 
study, the pathological department of the same 
hospital was taken into a liaison. 
Clinical specimen of apparent pus and wound 
discharge from clinically suspected SSI patients was 
taken under full aseptic measures in a sterile container. 
They were sent to the pathological department with a 
patient profile under sterile conditions for culture and 
sensitivity examination. In the laboratory, these 
samples were inoculated on blood, chocolate, and 
MacConkey agar and were then incubated at 370C for 
24 hours. Isolates were identified by their colony 
morphology, Gram reaction, catalase test, and Oxidase 
test. A coagulation test was done for the identification 
of Staphylococcus(S) aureus. Species identification of 
Gram –ve bacilli was done by using API 20E 
(BioMerieux). Methicillin-resistant Staph aureus was 
detected by using Cefoxitin disc (30µg). Bacterial 
suspensions of isolates equivalent to 0.5McFarland, s 
turbidity standard were prepared and inoculated on 
Mueller-Hinton agar plates. It was followed by the 
application of various antibiotic discs (Oxoid, UK) as 
per the manufacturer’s instructions. The plates were 
then incubated at 37oC aerobically for 24 hours. Zone 
diameters for each antibiotic were measured and 
interpreted as susceptible or resistant, according to 
Clinical and Laboratory Standards Institute (CLSI) 
guidelines. Statistical analysis of data was done using 
Statistical Package for Social Sciences version 21 (SPSS 
21). Frequencies and percentages were calculated for 





Out of the total 2202 operated patients, 237(10.76%) 
developed surgical site infection (SSI).  




Figure: Surgical site infections 
 
One hundred and fifty-five (65.40%) SSI patients were 
male and eighty-two (35.59%) were female. The most 
involved age groups were 11-20 and 21-30years 
(30.80% and 27.00%) respectively.  Of the total 237 
patients with SSI, fifty (21.09%) had laparotomy for 
acute abdomen, seventy (29.09%) had laparotomy for 
penetrating and blunt abdominal trauma and thirty-
five (14.76%) had appendectomy. (Table 1) 
 
Table 1: Demographic and pathological 











11-20 73 30.80 
21-30 64 27.00 
31-40 40 16.87 
41-50 37 15.61 
51-60 23 09.70 
Gender  
 
Male  155 65.40 
















 Open fractures 20 8.43 
 Debridement 














 Fasciotomy 2 0.84 
 Miscellaneous 4 01.68 
Growth  Mono growth  152 64.13 
Poly growth  85 35.86 
 
One hundred and thirty-nine (58.64%) patients' wounds were contaminated at the time of surgery while forty-
nine (20.67%) were dirty. (Table 2) 
 
Table 2: Distribution of SSI cases according to the presence of contamination 
Serial  
No 
Procedure  clean Clean 
contaminated 
contaminated dirty Total 
1 Laparotomy for blunt and 
penetrating abdominal trauma 
0 15 50 5 70 
2 Laparotomy for acute 
abdomen 
0 2 35 13 50 
3 Appendicectomy 0 14 16 5 35 
4 Debridement of Gangrenous 
wounds 
0 2 12 13 27 
5 Management of type 3 & 4 
open fractures 
0 9 8 3 20 
6 Below knee amputation  0 0 5 4 09 
7 Above knee amputation  0 0 2 2 04 
8 Surgeries for complicated 
hernias  
0 2 3 2 07 
9 Fasciotomies  0 1 1 0 02 
261                                                                             Journal of Rawalpindi Medical College (JRMC); 2021; 25(2): 258-263 
 
10 Miscellaneous 0 0 2 2 04 











Gram-positive organisms were identified in seventy-
three percent of SSI patients and Gram-negative 
organisms were reported in twenty-six percent. Staph 
aureus was the commonest organism detected. (Table 
3)  
Table 3: Micro-organisms distribution 











Staph aureus 145 79.67 
Enterococcus 18 9.80 
Streptococcus 11 6.04 
Clostridium 06 3.29 





E.coli 39 70.90 





Most of the organisms were resistant to the commonly 
used antibiotics like Ceftriaxone and Ciprofloxacin. 
Twelve out of one hundred and eighty-two (6.59%) 
Staph aureus cultures were Methicillin-resistant Staph 
aureus (MRSA) while two patients (1.09%) had 
Vancomycin-resistant Staph aureus (VRSA). Six (50%) 
MRSA patients were sensitive to Linezolid and six 
(50%) MRSA patients were sensitive to Vancomycin. 
Two (0.84%) patients were sensitive to Tigecyclin. 
(Table 4) 
 
Table 4: Antibiotics to which the organisms were 
found to be sensitive after report of C/S 




1 Cefoperazone 46 19.40 
2 Amoxicillin 16 6.75 
3 Ceftriaxone 09 3.79 
4 Ciprofloxacin 09 3.79 
5 Piperacillin 20 8.43 
6 Clarithromycin 09 3.79 
7 Metronidazole 43 18.40 
8 Amikacin 21 8.86 
9 Tigecyclin 02 0.84 
10 Linezolid 21 8.86 
11 Doxycycline 09 3.79 
12 Vancomycin  09 3.79 





The present study was conducted on 2,202 patients 
who underwent emergency surgeries. The incidence of 
surgical site infection varies worldwide from 2.5% to 
41.9% as per different studies.6 Incidence of SSI in our 
study was 10.76%, Cruse P et al reported incidence of 
04.7%.18 While Anvikar AR et al reported a rate of 
6.1%.4 About sixty-five percent of patients in our study 
were male. The preponderance is also reported by 
many other studies like Hafeez A et al (60.7%).19,20,21 
This might be due to the more incidence of penetrating 
and blunt abdominal trauma that occurs in males. The 
incidence of SSI was higher in younger age groups. 
This might be because most of our study population 
was young due to the high poly trauma rate in young 
people. Kayel KS et al recorded higher older age 
incidence.22 In our study 21.09% of SSI cases 
underwent laparotomies for acute abdomen.  Most of 
the acute abdomen causes were perforated peptic 
ulcer, perforated appendix, enteric perforation, and 
intestinal perforation proximal to obstructed gut due 
to ileocecal tuberculosis and rectosigmoid tumors. 
Such patients were mostly in sepsis due to 
contamination and shock due to multisystem injury at 
the time of presentation. This fact jeopardizes the 
immune system of the patients.23 Such an observation 
was also noticed by Lilani et al6, Cruse PJE et al7, 
Prospero E et al.24 In our study 29.53% of SSI patients 
underwent laparotomy for penetrating and blunt 
abdominal trauma. Most of these patients had multiple 
gut injuries and solid viscera injuries like liver or 
splenic laceration causing feculent and chemical 
peritonitis. These contaminating factors increase the 
chance of the development of SSI. Such findings were 
also observed by Anvikar AR4 and Lilani et al.6 In our 
study mono microbial flora was 64.13% while 
polymicrobial flora was 35.86%. Rolston KV et al9 
found a monomicrobial rate of 42% while in another 
study Bowler PG et al25 found more incidence of 
polymicrobial flora. 
In our study Staph aureus was the commonest Gram 
+ve organism observed in one hundred and forty-five 
(79.67%) patients, followed by Enterococcus and 
streptococcus. Such finding was also observed by 
Chamber D et al26 Anderson DJ et al27, Lilani SP et al6.  
E.coli was the commonest Gram-ve organism in our 
study present in thirty-nine (70.67%) patients, 
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followed by Klebsiella and P.aeruginosa. Similar 
findings were reported by Madappa T.28 
The most commonly used empirical antibiotics were 
Co-amoxiclave, Ceftriaxone, Ciprofloxacin, and 
Cefoperazone used either monotherapy or in different 
combinations. Metronidazole was prescribed for 
anaerobic coverage. These medicines were used 
because they were available in the hospital pharmacy.  
In our study 19.40% of patients were sensitive to 
Cefoperazone, 8.86% to Amikacin and Linezolid each, 
8.43% to Piperacillin followed by 3.79% to 
Vancomycin, Doxycyclin, Ciprofloxacin 
Clarithromycin, and Ceftriaxone each and 6.75% to 
Co-amoxiclav. 9.70% of patients had mixed sensitivity. 
This trend shows that isolated bacteria are becoming 
resistant to the commonly used empirical antibiotics as 
stated earlier. These strains are sensitive to new broad-
spectrum antibiotics as Linezolid and Piperacillin. 
Such a drug resistance pattern was also observed by 
Kamath N et al29, Anvikar AR et al4, and Lilani SP et 
al6. Most of the newer antibiotics are much costly and 
generally not available in the hospital pharmacy of our 
hospital. They have to be purchased from private 
pharmacies at a high cost putting an extra financial 
burden on the hospital resources which is also shown 
by other studies like Jenks PJ et al.30  
Twelve out of one hundred and eighty-two (6.59%) 
Staph aureus cultures were Methicillin-resistant Staph 
aureus (MRSA) while two patients (1.09%) had 
Vancomycin-resistant Staph aureus (VRSA). Six (50%) 
MRSA patients were sensitive to Linezolid and six 
(50%) MRSA patients were sensitive to Vancomycin. 
Two VRSA (Vancomycin-resistant Staph aureus) 
strains were sensitive to Linezolid. This shows the 
good efficacy of these new antibiotics. Dodds ES et 
al32, Moore M33, and Marin H34 also observed such 
sensitivity against MRSA. 
In two (0.84%) SSI patients managed in intensive care 
unit after surgery, Acinetobacter was found which was 




Increased incidence of blunt abdominal trauma 
increases the chances of SSI, so every possible effort 
should be made to decrease this incidence by better 
traffic regulations. Adequate pre-op resuscitation and 
peri-operative sterilization can decrease the incidence 
of surgical site infections. Thorough per operative 
wound wash decreases the spread of contamination 
which can lead to a decrease incidence of SSI. The 
spread of Staph aureus can be decreased by avoiding 
direct contact with an infected wound and wearing 
gloves and masks by all healthcare providers.  Routine 
antibiotics like Co-Amoxiclave, Ceftriaxone, and 
Ciprofloxacin can be prescribed in clean-contaminated 
cases. Newer broad-spectrum antibiotics like 
Piperacillin, Cefoperazone, and Linezolid should be 
prescribed to cover all strains of pathogens especially 
emerging strains of MRSA more commonly reported 
in contaminated and dirty cases. Antibiotics like 
Tigecyclin and Fosfomycin can be considered in post-
operative patients being managed in intensive care 
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